论文部分内容阅读
玻璃体手术是治疗增生性糖尿病视网膜病变(PDR)的有效手段。多数年龄在50岁以上的糖尿病患者会发生晶状体混浊或晶状体核硬化,晶状体混浊不仅直接影响患者视力,且对术中纤维血管膜剥离、周边玻璃体切除以及周边部视网膜光凝等均会造成一定的困难。因此PDR患者在接受玻璃体手术时面临的一个常见问题就是如何处理晶状体。是在玻璃体切除的同时切除晶状体还是在玻璃体切除术后待白内障成熟时再行第二次手术呢?为此,我们组织北京同仁医院眼科中心眼底病亚科的四位医师谈谈他们的主张及理由。
Vitreous surgery is an effective treatment for proliferative diabetic retinopathy (PDR). Most patients with diabetes over the age of 50 will experience lens opacification or lens nuclear sclerosis. Lens opacity not only directly affects the patient’s visual acuity, but also causes some intraoperative fibroplasmic membrane debridement, peripheral vitrectomy, and peripheral retinal photocoagulation difficult. Therefore, a common problem faced by PDR patients during vitreous surgery is how to treat the lens. In addition to the removal of the lens during vitrectomy or the second surgery after cataract maturation after vitrectomy, we organized four physicians in the Department of Ophthalmology, Beijing Tongren Hospital Ophthalmology Center to discuss their opinions and reason.